Back
Baxter International Inc (BAX)
Health CareBAX · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$24.36
+1.86%Weekly undervalued picks (like BAX)
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$-1.87
ROE
-15.0%
Gross margin
34.6%
Debt/Equity
1.61x
Revenue growth
2.9%
Baxter International Inc — company intelligence
Earnings surprises
Q2 2026$0.56 vs $0.37 est+51.5%
Q1 2026$0.36 vs $0.31 est+15.9%
Q4 2025$0.44 vs $0.54 est-18.7%
Q3 2025$0.69 vs $0.60 est+14.2%
Analyst consensus · 20 analysts
5 Buy14 Hold1 Sell
Updated Oct 9, 2026
Recent SEC filings
4 — Insider transaction reportSep 3, 2026
4 — Insider transaction reportSep 3, 2026
4 — Insider transaction reportSep 3, 2026
Latest news
Is Baxter Stock Underperforming the Nasdaq? — Yahoo · 2w ago
Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript — SeekingAlpha · Sep 9, 2026
Reported Earlier, Medline Prices Secondary Offering Of 75M Class A Shares At $41.00/Share By Blackstone, Carlyle, Hellman & Friedman And ADIA Affiliates — Benzinga · Sep 8, 2026
Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA — Yahoo · Sep 7, 2026
3 Value Stocks We Keep Off Our Radar — Yahoo · Sep 3, 2026
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks (like BAX)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.